Expression and biological function of N-myc down-regulated gene 1 in human cervical cancer

Abstract

The expression of N-myc down-regulated gene 1 (NDRG1) has previously been reported to be involved in the proliferation, differentiation, invasion and metastasis of cancer cells, but its role in cervical cancer is still unclear. This study aimed to investigate the expression of NDRG1gene in human cervical cancer and its effect on aggressive tumor behaviors. The NDRG1 expression in cervical tissues and cells was detected by RT-PCR. Specific expression plasmid pEGFP-N1-NDRG1-GFP was used to enhance the expression of NDRG1 in human cervical cancer cell lines. The mRNA and protein level of NDRG1 was assessed by RT-PCR and Western blotting, respectively. Its effects on cell proliferation, migration, invasion, cell cycle and apoptosis were detected by MTT, transwell migration assay and flow cytometry (FCM), respectively. The results showed that the expression of NDRG1 in cervical cancer tissues and cells was significantly lower than in normal cervical tissues (P<0.001). After transfection with pEGFP-N1-NDRG1-GFP, the mRNA and protein expression of NDRG1 was up-regulated in Siha cells, which suppressed cell proliferation (P<0.001), induced cell cycle arrest (P<0.05), reduced invasion and migration of Siha cells (P<0.05), but caused no cell apoptosis. Moreover, vascular endothelial growth factor (VEGF), a tumor-induced angiogenesis factor, was markedly reduced and E-cadherin, a cell adhesion molecule, was increased in the cells transfected with pEGFP-N1-NDRG1-GFP. It was concluded that up-regulated NDRG1 may play a role in the suppression of malignant cell growth, invasion and metastasis of human cervical cancer.

Keywords

N-myc down-regulated gene 1 / cervical cancer / transfection / cell proliferation / invasion

References

[1] LachatP., ShawP., GebhardS., et al.. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol, 2002, 118(5): 399-408

[2] ZhouR.H., KokameK., TsukamotoY., et al.. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics, 2001, 73(1): 86-97

[3] KurdistaniS.K., AriztiP., ReimerC.L., et al.. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res, 1998, 58(19): 4439-4444

[4] SteinS., ThomasE.K., HerzogB., et al.. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem, 2004, 279(47): 48930-48940

[5] MaruyamaY., OnoM., KawaharaA., et al.. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res, 2006, 66(12): 6233-6242

[6] BobryshevY.V., LordR.S., WatanabeT., et al.. The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. Cardiovasc Res, 1998, 40(1): 191-205

[7] BandyopadhyayS., PaiS.K., HirotaS., et al.. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene, 2004, 23(33): 5675-5681

[8] BandyopadhyayS., PaiS.K., GrossS.C., et al.. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res, 2003, 63(8): 1731-1736

[9] GuanR.J., FordH.L., FuY., et al.. Drg-1 as a differentiation- related, putative metastatic suppressor gene in human colon cancer. Cancer Res, 2000, 60(3): 749-755

[10] van BelzenN., DinjensW.N., DiesveldM.P., et al.. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest, 1997, 77(1): 85-92

[11] ShahM.A., KemenyN., HummerA., et al.. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res, 2005, 11(9): 3296-3302

[12] YanX., ChuaM.S., SunH., et al.. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett, 2008, 262(1): 133-142

[13] CangulH., SalnikowK., YeeH., et al.. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect, 2002, 110(Suppl5): 783-788

[14] WangZ., WangF., WangW.Q., et al.. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol, 2004, 10(4): 550-554

[15] ShimonoA., OkudaT., KondohH.. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev, 1999, 83(1–2): 39-52

[16] BandyopadhyayS., PaiS.K., HirotaS., et al.. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res, 2004, 64(21): 7655-7660

[17] KeyomarsiK., SandovalL., BandV., et al.. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res, 1991, 51(13): 3602-3609

[18] KeyomarsiK., PardeeA.B.. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A, 1993, 90(3): 1112-1116

[19] van BelzenN., DinjensW.N., EussenB.H., et al.. Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. Histol, 1998, 13(4): 1233-1242

[20] van BelzenN., DiesveldM.P., van der MadeA.C., et al.. Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur J Biochem, 1995, 234(3): 843-848

[21] TakeichiM.. Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 1991, 251(5000): 1451-1455

[22] SatoN., KokameK., ShimokadoK., et al.. Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others. J Biochem, 1998, 123(6): 1119-1126

[23] BiankinA.V., MoreyA.L., LeeC.S., et al.. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarci noma. J Clin Oncol, 2002, 20(23): 4531-4542

[24] UeharaH., MiyamotoM., KatoK., et al.. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res, 2004, 64(10): 3533-3537

[25] IkedaN., AdachiM., TakiT., et al.. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer, 1999, 79(9–10): 1553-1563

[26] ShimamuraT., SakamotoM., InoY., et al.. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. J Clin Oncol, 2003, 21(4): 659-667